Thyrocare Technologies Ltd
BSE:539871

Watchlist Manager
Thyrocare Technologies Ltd Logo
Thyrocare Technologies Ltd
BSE:539871
Watchlist
Price: 468.95 INR 3.53% Market Closed
Market Cap: 24.8B INR

Intrinsic Value

The intrinsic value of one THYROCARE stock under the Base Case scenario is 307.53 INR. Compared to the current market price of 468.95 INR, Thyrocare Technologies Ltd is Overvalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

THYROCARE Intrinsic Value
307.53 INR
Overvaluation 34%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Thyrocare Technologies Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about THYROCARE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is THYROCARE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Thyrocare Technologies Ltd.

Explain Valuation
Compare THYROCARE to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about THYROCARE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Thyrocare Technologies Ltd

Current Assets 3.2B
Cash & Short-Term Investments 1.9B
Receivables 754.9m
Other Current Assets 539.4m
Non-Current Assets 3.6B
Long-Term Investments 322.6m
PP&E 1.9B
Intangibles 1.1B
Other Non-Current Assets 201.5m
Current Liabilities 1.2B
Accounts Payable 660.1m
Other Current Liabilities 560.6m
Non-Current Liabilities 239.3m
Long-Term Debt 167.5m
Other Non-Current Liabilities 71.8m
Efficiency

Free Cash Flow Analysis
Thyrocare Technologies Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Thyrocare Technologies Ltd

Revenue
7.6B INR
Cost of Revenue
-2.1B INR
Gross Profit
5.5B INR
Operating Expenses
-3.8B INR
Operating Income
1.7B INR
Other Expenses
-472.1m INR
Net Income
1.3B INR
Fundamental Scores

THYROCARE Profitability Score
Profitability Due Diligence

Thyrocare Technologies Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
ROIC is Increasing
Exceptional Gross Margin
Positive ROE
63/100
Profitability
Score

Thyrocare Technologies Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

THYROCARE Solvency Score
Solvency Due Diligence

Thyrocare Technologies Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
96/100
Solvency
Score

Thyrocare Technologies Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

THYROCARE Price Targets Summary
Thyrocare Technologies Ltd

Wall Street analysts forecast THYROCARE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for THYROCARE is 587.63 INR with a low forecast of 528.51 INR and a high forecast of 660.38 INR.

Lowest
Price Target
528.51 INR
13% Upside
Average
Price Target
587.63 INR
25% Upside
Highest
Price Target
660.38 INR
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for THYROCARE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one THYROCARE stock?

The intrinsic value of one THYROCARE stock under the Base Case scenario is 307.53 INR.

Is THYROCARE stock undervalued or overvalued?

Compared to the current market price of 468.95 INR, Thyrocare Technologies Ltd is Overvalued by 34%.

Back to Top